LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
HAO BAI INTL (08431): Zhang Jiaqing appointed as executive director
Xinming China (02699) plans to conduct a rights issue based on a "1 for 6" ratio, with a net fundraising amount of approximately HK$101 million.
DINGDANG HEALTH(09886): Meng Fanzhou appointed as Executive Director and Vice President.
HAO BAI INTL (08431): Zhang Jiaqing appointed as executive director
Xinming China (02699) plans to conduct a rights issue based on a "1 for 6" ratio, with a net fundraising amount of approximately HK$101 million.
DINGDANG HEALTH(09886): Meng Fanzhou appointed as Executive Director and Vice President.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
